Wikidata

(Q38245311)

English

Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy

scientific article published on August 2014

In more languages

Statements

title
Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
25178642
retrieved
31 August 2017
author name string
Rakesh Singal
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
25178642
retrieved
31 August 2017
Kavitha Ramachandran
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
25178642
retrieved
31 August 2017
Edna Gordian
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
25178642
retrieved
31 August 2017
Carlos Quintero
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
25178642
retrieved
31 August 2017
Isildinha M Reis
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
25178642
retrieved
31 August 2017
publication date
1 August 2014
1 reference
stated in
Europe PubMed Central
PubMed ID
25178642
retrieved
31 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q38245311&oldid=1842594657"